Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christiaan H Arendzen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Protocols in Stem Cell Biology|September 21, 2020
Reprogramming Urine-Derived Cells using Commercially Available Self-Replicative RNA and a Single ElectroporationMarga J Bouma, Christiaan H Arendzen, Christine L Mummery, et al.
Stem Cell Research|June 16, 2021
Generation of human induced pluripotent stem cell line EURACi006-A and its isogenic gene-corrected line EURACi006-A-1 from an arrhythmogenic cardiomyopathy patient carrying the c.1643delG PKP2 mutationViviana Meraviglia, Sravya Ganesh, Christiaan H Arendzen, et al.
Stem Cell Research|April 22, 2020
Generation of two human induced pluripotent stem cell lines, LUMCi020-A and LUMCi021-A, from two patients with Catecholaminergic Polymorphic Ventricular Tachycardia carrying heterozygous mutations in the RYR2 geneViviana Meraviglia, Christiaan H Arendzen, Christian Freund, et al.
Stem Cell Research|June 3, 2020
Generation of human induced pluripotent stem cell line LUMCi027-A and its isogenic gene-corrected line from a patient affected by arrhythmogenic cardiomyopathy and carrying the c.2013delC PKP2 mutationViviana Meraviglia, Christiaan H Arendzen, Merve Tok, et al.
Stem Cell Reports|April 21, 2023
AAV-mediated gene augmentation therapy of CRB1 patient-derived retinal organoids restores the histological and transcriptional retinal phenotypeNanda Boon, Xuefei Lu, Charlotte A Andriessen, et al.
Stem Cell Reports|June 14, 2023
AAV-mediated gene augmentation therapy of CRB1 patient-derived retinal organoids restores the histological and transcriptional retinal phenotypeNanda Boon, Xuefei Lu, Charlotte A Andriessen, et al.
Cytotherapy|March 14, 2024
Good Manufacturing Practice-compliant human induced pluripotent stem cells: from bench to putative clinical productsJuan J Novoa, Inge M Westra, Esther Steeneveld, et al.
Stem Cell Reports|August 4, 2023
CRB1 is required for recycling by RAB11A+ vesicles in human retinal organoidsThilo M Buck, Peter M J Quinn, Lucie P Pellissier, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Protocols in Stem Cell Biology|September 21, 2020
Reprogramming Urine-Derived Cells using Commercially Available Self-Replicative RNA and a Single ElectroporationMarga J Bouma, Christiaan H Arendzen, Christine L Mummery, et al.
Stem Cell Research|June 16, 2021
Generation of human induced pluripotent stem cell line EURACi006-A and its isogenic gene-corrected line EURACi006-A-1 from an arrhythmogenic cardiomyopathy patient carrying the c.1643delG PKP2 mutationViviana Meraviglia, Sravya Ganesh, Christiaan H Arendzen, et al.
Stem Cell Research|April 22, 2020
Generation of two human induced pluripotent stem cell lines, LUMCi020-A and LUMCi021-A, from two patients with Catecholaminergic Polymorphic Ventricular Tachycardia carrying heterozygous mutations in the RYR2 geneViviana Meraviglia, Christiaan H Arendzen, Christian Freund, et al.
Stem Cell Research|June 3, 2020
Generation of human induced pluripotent stem cell line LUMCi027-A and its isogenic gene-corrected line from a patient affected by arrhythmogenic cardiomyopathy and carrying the c.2013delC PKP2 mutationViviana Meraviglia, Christiaan H Arendzen, Merve Tok, et al.
Stem Cell Reports|April 21, 2023
AAV-mediated gene augmentation therapy of CRB1 patient-derived retinal organoids restores the histological and transcriptional retinal phenotypeNanda Boon, Xuefei Lu, Charlotte A Andriessen, et al.
Stem Cell Reports|June 14, 2023
AAV-mediated gene augmentation therapy of CRB1 patient-derived retinal organoids restores the histological and transcriptional retinal phenotypeNanda Boon, Xuefei Lu, Charlotte A Andriessen, et al.
Cytotherapy|March 14, 2024
Good Manufacturing Practice-compliant human induced pluripotent stem cells: from bench to putative clinical productsJuan J Novoa, Inge M Westra, Esther Steeneveld, et al.
Stem Cell Reports|August 4, 2023
CRB1 is required for recycling by RAB11A+ vesicles in human retinal organoidsThilo M Buck, Peter M J Quinn, Lucie P Pellissier, et al.
Pageof 1